SE460481B - Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning - Google Patents

Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning

Info

Publication number
SE460481B
SE460481B SE8404929A SE8404929A SE460481B SE 460481 B SE460481 B SE 460481B SE 8404929 A SE8404929 A SE 8404929A SE 8404929 A SE8404929 A SE 8404929A SE 460481 B SE460481 B SE 460481B
Authority
SE
Sweden
Prior art keywords
bbm
antibiotic
strain
medium
formula
Prior art date
Application number
SE8404929A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404929L (sv
SE8404929D0 (sv
Inventor
M Konishi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8404929D0 publication Critical patent/SE8404929D0/xx
Publication of SE8404929L publication Critical patent/SE8404929L/xx
Publication of SE460481B publication Critical patent/SE460481B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8404929A 1983-10-03 1984-10-02 Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning SE460481B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,453 US4518589A (en) 1983-10-03 1983-10-03 BBM-2478 Antibiotic complex

Publications (3)

Publication Number Publication Date
SE8404929D0 SE8404929D0 (sv) 1984-10-02
SE8404929L SE8404929L (sv) 1985-04-04
SE460481B true SE460481B (sv) 1989-10-16

Family

ID=24146999

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404929A SE460481B (sv) 1983-10-03 1984-10-02 Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning

Country Status (29)

Country Link
US (1) US4518589A (fr)
JP (2) JPS60115599A (fr)
AT (1) AT381507B (fr)
AU (1) AU570271B2 (fr)
BE (1) BE900735A (fr)
CA (1) CA1242159A (fr)
CH (1) CH666043A5 (fr)
CY (1) CY1534A (fr)
DE (1) DE3436137C2 (fr)
DK (1) DK473484A (fr)
ES (1) ES536455A0 (fr)
FI (1) FI79141C (fr)
FR (1) FR2555586B1 (fr)
GB (1) GB2147582B (fr)
GR (1) GR80551B (fr)
HK (1) HK82790A (fr)
HU (1) HU192461B (fr)
IE (1) IE57825B1 (fr)
IL (1) IL73126A (fr)
IT (1) IT1176854B (fr)
LU (1) LU85572A1 (fr)
MX (1) MX9202848A (fr)
MY (1) MY101664A (fr)
NL (1) NL8403002A (fr)
OA (1) OA07827A (fr)
PT (1) PT79310B (fr)
SE (1) SE460481B (fr)
SU (1) SU1423001A3 (fr)
ZA (1) ZA847723B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859598A (en) * 1984-03-26 1989-08-22 American Cyanamid Company Antibiotic LL-D42067β
US4626503A (en) * 1984-04-04 1986-12-02 American Cyanamid Company Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
NZ211872A (en) * 1984-04-27 1989-06-28 Ishihara Sangyo Kaisha Chartreusin derivatives and antitumorous compositions
ATE72447T1 (de) * 1985-10-23 1992-02-15 Ishihara Sangyo Kaisha Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
CA2008766C (fr) * 1989-01-30 1997-03-04 Nobutoshi Yamada Exo-3',4'-0-benzylidne-3''-dimethylchartreusine et ses sels
IN172911B (fr) * 1991-02-26 1994-01-01 Hoechst India
US5229371A (en) * 1991-05-30 1993-07-20 Bristol-Myers Squibb Company Chemical modification of elsamicin A at the 3' and/or 4' OH groups
ZA923818B (en) * 1991-05-30 1993-11-25 Bristol Myers Squibb Co Chemical modification of 2"-amino group in elsamicin A
HU210492B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for preparing novel 6-0-acyl deriv.s of elsamicin a and pharmaceutical copn.s contg. them
US5237055A (en) * 1991-05-30 1993-08-17 Bristol-Myers Squibb Company Chemical modification of 2"-amino group in elsamicin A
HU210162B (en) * 1991-05-30 1995-02-28 Bristol Myers Squibb Co Process for preparing 3',4'-o-substituted elsamicin a deriv.s and pharmaceutical compn.s contg. them
ZA923816B (en) * 1991-05-30 1993-11-25 Bristol Myers Squibb Co Prepartion of 6-0-alkylesamicin a derivatives
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations
WO2008092103A2 (fr) * 2007-01-25 2008-07-31 Spectrum Pharmaceuticals, Inc. Traitements de cancer par combinaison comprenant de l'elsamitrucine et d'autres agents
MX2008015971A (es) * 2007-05-24 2009-01-12 Spectrum Pharmaceuticals Inc Sales de elsamitrucina estables adecuadas para formulaciones farmaceuticas.
EP2222276A1 (fr) * 2007-12-19 2010-09-01 Spectrum Pharmaceuticals, Inc. Formulations de sel d'elsamitrucine stables
JP2009207970A (ja) * 2008-03-03 2009-09-17 Marsima Aqua System Corp 空気揚水装置
CN111751469B (zh) * 2020-07-06 2022-06-14 江苏省中医院 一种液相色谱串联质谱测定血浆中教酒菌素浓度的方法

Also Published As

Publication number Publication date
CH666043A5 (de) 1988-06-30
IE842511L (en) 1985-04-03
JPH0641182A (ja) 1994-02-15
IT8422961A0 (it) 1984-10-03
GB8424810D0 (en) 1984-11-07
HU192461B (en) 1987-06-29
IL73126A0 (en) 1984-12-31
GB2147582A (en) 1985-05-15
FR2555586A1 (fr) 1985-05-31
DE3436137C2 (de) 1993-12-02
FI79141B (fi) 1989-07-31
HK82790A (en) 1990-10-19
ES8602135A1 (es) 1985-11-16
DK473484A (da) 1985-04-04
IL73126A (en) 1989-05-15
NL8403002A (nl) 1985-05-01
MX9202848A (es) 1992-06-30
FI79141C (fi) 1989-11-10
AT381507B (de) 1986-10-27
HUT37170A (en) 1985-11-28
DE3436137A1 (de) 1985-05-15
IT8422961A1 (it) 1986-04-03
ZA847723B (en) 1985-05-29
FR2555586B1 (fr) 1988-10-07
ES536455A0 (es) 1985-11-16
SE8404929L (sv) 1985-04-04
CA1242159A (fr) 1988-09-20
PT79310A (en) 1984-11-01
SU1423001A3 (ru) 1988-09-07
IT1176854B (it) 1987-08-18
MY101664A (en) 1991-12-31
DK473484D0 (da) 1984-10-02
JPS60115599A (ja) 1985-06-22
GB2147582B (en) 1987-04-15
OA07827A (fr) 1986-11-20
IE57825B1 (en) 1993-04-21
GR80551B (en) 1985-02-06
PT79310B (en) 1986-11-14
ATA313184A (de) 1986-03-15
FI843823L (fi) 1985-04-04
JPH0566394B2 (fr) 1993-09-21
SE8404929D0 (sv) 1984-10-02
AU570271B2 (en) 1988-03-10
FI843823A0 (fi) 1984-09-28
CY1534A (en) 1990-11-16
LU85572A1 (fr) 1985-06-19
US4518589A (en) 1985-05-21
AU3354884A (en) 1986-09-11
BE900735A (fr) 1985-04-02
JPH0689017B2 (ja) 1994-11-09

Similar Documents

Publication Publication Date Title
SE460481B (sv) Antibiotiska antitumoerkomplex bbm-2478a och bbm-2478b samt foerfarande foer deras framstaellning
EP0277621B1 (fr) Antibiotiques antifongiques
US4552842A (en) Process for producing rebeccamycin
US4487925A (en) Rebeccamycin and process for its preparation
US4990448A (en) Bu-4061T
US5071957A (en) Antibiotic BU-4061T
US4524145A (en) 4'-Deschlororebeccamycin pharmaceutical composition and method of use
EP0182152B1 (fr) Antibiotiques antitumoraux (complexe LL-E33288)
CA1230568A (fr) Antibiotique antitumoral
CA2061239C (fr) Derives polyhydroxycyclopentane, leur preparation et leur utilisation therapeutique
KR920001448B1 (ko) Bbm-2478 항생제 착화합물
US4572895A (en) Process for preparing an antibiotic complex by culturing actinomyces strain ATCC 39417
US4626503A (en) Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
US4990497A (en) Antifungal antibiotics
EP0157203A2 (fr) Agents antitumoraux LL-D49194 alpha 1, LL-D49194 bêta 1, LL-D49194 bêta 2, LL-D49194 bêta 3, LL-D49194 gamma, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 dzéta, LL-D49194 êta LL-D499194 oméga 1, LL-D49194 oméga 2 et LL-D49194 oméga 3
US5002959A (en) BU-4146T antibiotic
JPH08512330A (ja) 海洋放線菌から単離した新規なチオデプシペプチド
US4499075A (en) Antibiotic agents from S. coeruleorubidus, rubidus
US5110960A (en) Antifungal antibiotics
US5036010A (en) BMY-40800 antitumor antibiotics
US5037836A (en) BU-4146T antibiotic
US5919671A (en) Antitumor antibiotic BMS-199687
EP0175284A2 (fr) Antibiotiques, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0479505A1 (fr) Pradimicins L et FL et leurs dérivés
EP0431323A1 (fr) Antibiotique antitumoral BU-3983T

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404929-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404929-5

Format of ref document f/p: F